Pay in 4 interest-free payments of $5.13 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
A study has been launched to look into a potential genetic risk after hundreds of people reported problems with their pancreas after taking weight loss drugs
Many people researching GLP-1 and metabolic peptides want to know what happens after stopping treatment, how long the effects last, and whether theres a safe way to transition off without major appetite rebound or unwanted side effects
High expression of nicotinamide N-methyltransferase in patients with obesity and insulin resistance
All products are manufactured following strict quality control standards to ensure safety and efficacy
The company posted a $99 million net loss in the first quarter of 2026, swinging from a $395 million profit in the same period a year earlier, as the elimination of a U.S
US$ 25.20
US$ 21.95
US$ 29.09
US$ 28.25
